Clinical Trial Update: Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors

View source ↗

Summary

A ClinicalTrials.gov update describing a trial focused on pharmacogenomics and circulating biomarkers for CDK4/6 inhibitors in breast cancer, including pharmaco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitors

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: CDK4/6 Inhibitor, Breast Cancer | Status: ENROLLING_BY_INVITATION